Table 2.

Dogs given 213Bi-anti-CD45 mAb (0.5 mg/kg) and DLA-identical marrow grafts

DogWeight (kg)Anti-CD45 mAb (mg/kg)213Bi (mCi/kg)[MBq/kg]Marrow MNCs (× 108/kg)GVHDDonor chimerism in MNCs (% range)Survival (wk)*
E889 (R) 10.8 0.5 4.6 [170] 5.3 No 30-70 > 39 
E886 (D)       
E805 (R) 11.2 0.5 3.6 [133] 4.4 No 40-50 > 39 
E806 (D)       
E885 (R) 6.3 0.5 8.8 [326] 4.5 No 40-95 > 27 
E893 (D)       
DogWeight (kg)Anti-CD45 mAb (mg/kg)213Bi (mCi/kg)[MBq/kg]Marrow MNCs (× 108/kg)GVHDDonor chimerism in MNCs (% range)Survival (wk)*
E889 (R) 10.8 0.5 4.6 [170] 5.3 No 30-70 > 39 
E886 (D)       
E805 (R) 11.2 0.5 3.6 [133] 4.4 No 40-50 > 39 
E806 (D)       
E885 (R) 6.3 0.5 8.8 [326] 4.5 No 40-95 > 27 
E893 (D)       

213Bi indicates bismuth 213; mAb, monoclonal antibody; MNCs, mononuclear cells; GVHD, graft-versus-host disease; R, recipient; and D, donor.

*

All dogs were euthanized on completion of the study.

Close Modal

or Create an Account

Close Modal
Close Modal